Report

Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: lung and prostate cancers

Publisher
Lung cancer Cancer Cancer screening Australia
Resources
Attachment Size
Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: lung and prostate cancers 2.93 MB
Description

This report provides findings from an analysis of Medicare Benefits Schedule (MBS) data for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. These analyses focus on changes in cancer-related diagnostic and treatment procedures for lung and prostate cancers.

Publication Details
ISBN:
978-1-74127-359-5
Copyright:
Cancer Australia 2020
Access Rights Type:
open
Post date:
13 Nov 2020

Add to favourites


More like this
Journal article

Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers

Strategy

Making lung cancer a fair fight: a blueprint for reform

Policy

Standards of service provision for lung cancer patients in New Zealand

Journal article

Assessing the efficacy of cancer screening

Evaluation

Analysis of bowel cancer outcomes for the National Bowel Cancer Screening Program 2018

Report

Independent Assurance Review for the National Bowel Screening Programme: final report

Journal article

Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates

Journal article

Improving breast cancer screening in Australia: a public health perspective

Journal article

Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches

Journal article

The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening